RecruitingNCT07490353
Psilocybin and pleasure-related responses in depression with anhedonia
About this title
Read the official source — NCT07490353Medication studyAges 18–55Austria
Understand this study
Who could participate?
Listed age limits: 18 years to 55 years.
What will I do during this study?
The protocol includes: Having magnetic resonance imaging (MRI) scans.
- Listed locations
- ViennaSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: November 1, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 85
- Sponsor
- Medical University of Vienna
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Diagnostic test, Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- Austria
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT07490353
- Official title
Show the full official title
Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects: A Randomized, Open-Label, Cross-Over Functional Magnetic Resonance Imaging Trial
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Vienna
Interested in joining this study?
Questions about this study
What will I need to do?
You will have MRI scans.
Who is behind this study?
The study sponsor is Medical University of Vienna, a university.
Does this study involve medication?
Yes. The study involves medication, including Psilocybin (Usona Institute) and Risperidone 1 MG.
Who can participate?
Listed age limits: 18 years to 55 years.
Is this study still recruiting?
The registry lists this study as recruiting.
Want to explore more studies?
Explore studiesRelated studies
Antidepressants, brain dopamine and reward in depression
The Effect of a Six Week Intensified Pharmacological Treatment for Depression in bipolarity Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.